Madecassic acid suppresses osteoclast differentiation and bone resorption by inhibiting RANKL‐induced NF‐κB, JNK and NFAT signaling pathways
Abstract Background Overproduction and activation of osteoclasts result in various bone diseases, such as osteoporosis, Paget's disease, and rheumatoid arthritis. Thus, inhibiting osteoclast formation and overactivation may effectively prevent osteoclast‐related bone diseases, especially osteop...
Main Authors: | Peiru Su, Xiangya Luo, Chunping Zeng, Lin Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Rheumatology & Autoimmunity |
Subjects: | |
Online Access: | https://doi.org/10.1002/rai2.12088 |
Similar Items
-
Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone loss
by: Xiaole Peng, et al.
Published: (2024-03-01) -
Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways
by: Huanhuan Xu, et al.
Published: (2022-05-01) -
Wheat seedling extract and its constituents attenuate RANKL-induced differentiation and fusion of osteoclasts and bone resorption
by: HanGyeol Lee, et al.
Published: (2023-09-01) -
Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
by: Seongtae Jeong, et al.
Published: (2020-08-01) -
Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis
by: Ye Xiaoshuang, et al.
Published: (2022-08-01)